Relieving Ehlers-Danlos Syndrome Pain with Compression Garments

The results of the NOVASED clinical study, demonstrating the benefits of our compression garments for EDS and HSD patients, were showcased at the 24th European Congress of Rheumatology (EULAR) in Vienna.

At NOVATEX MEDICAL, improving patients’ daily lives is at the heart of our approach. We have always been committed to developing adapted devices and rigorously proving their effectiveness. This is why we are particularly proud of the presentation of our NOVASED study results by Prof. Roland Jaussaud at this major international congress.

Concrete benefits proven over 26 months

This clinical study followed 107 patients suffering from hypermobile Ehlers-Danlos Syndrome (hEDS) or Hypermobility Spectrum Disorders (HSD) over a period of more than two years.

The real-world results confirm the positive and lasting impact of our compression garments:

• Pain reduction: 33.3% of patients report a decrease in their pain
• Reduction of fatigue: An improvement was noted in 40% of the participants
• Improved quality of life: 50% of patients saw their overall score improve by more than 10%
• Positive psychological impact: 35.3% of patients recorded a decrease in anxiety and depression
• Reduction in medication: 22% were able to reduce their daily intake of painkillers
  
  

The study also highlights excellent treatment adherence, with 93% of patients satisfied or very satisfied at the end of the 26 months.

Understanding the action of compression

The effectiveness of our devices is based on proprioception. Continuous compression stimulates the body’s sensory receptors. This mechanical action offers a double benefit: it partially “scrambles” the pain message sent to the brain, and it provides better spatial awareness to stabilize the joints, making movement safer.

A commitment to the future of patients

The initiation of this ambitious study by NOVATEX MEDICAL serves a fundamental objective: providing irrefutable clinical evidence to guarantee the long-term coverage of these devices by Health Insurance.

Every scientific breakthrough is a victory in ensuring that thousands of people have sustainable access to effective therapeutic solutions.